CN104587098A - Medicament for treating fatty liver - Google Patents

Medicament for treating fatty liver Download PDF

Info

Publication number
CN104587098A
CN104587098A CN201510058596.5A CN201510058596A CN104587098A CN 104587098 A CN104587098 A CN 104587098A CN 201510058596 A CN201510058596 A CN 201510058596A CN 104587098 A CN104587098 A CN 104587098A
Authority
CN
China
Prior art keywords
parts
radix
herba
fatty liver
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510058596.5A
Other languages
Chinese (zh)
Inventor
蔡炜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510058596.5A priority Critical patent/CN104587098A/en
Publication of CN104587098A publication Critical patent/CN104587098A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a medicament for treating fatty liver. The medicament is characterized by comprising the following components in parts by weight: 4-10 parts of herba epimedii, 3-6 parts of folium eriobotryae, 1-3 parts of radix glycyrrhizae, 2-5 parts of radix scutellariae, 2-7 parts of rhizoma alismatis, 3-10 parts of radix notoginseng, 2-6 parts of poria, 1-5 parts of fructus crataegi, 2-4 parts of herba artemisiae scopariae, 3-10 parts of fructus lycii, 3-8 parts of herba abri, 3-6 parts of gynostemma pentaphyllum, 1-5 parts of herba rhodiolae, 2-8 parts of radix salviae miltiorrhizae and 3-8 parts of green tea. The medicament has the efficacies of soothing the liver and regulating qi, resolving stasis eliminating phlegm and promoting blood circulation and removing stasis, the curative effect for treating fatty liver is definite, the effect is fast and good, and the medicament is safe and free from toxic and side effect.

Description

A kind of medicine for the treatment of fatty liver
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of medicine for the treatment of fatty liver.
Background technology
Along with the change of people's living and diet structure and the raising of medical imaging technology, fatty liver disease (i.e. fatty liver) sickness rate being called as modern times " affluenza " significantly improves, become the second largest frequently-occurring hepatopathy being only second to viral hepatitis, human health in serious threat.Probably there is Patients with Fatty Liver more than 8,000 ten thousand people in current China, just has one to be potential Patients with Fatty Liver in every 10 people.Fatty liver disease can be caused by multiple inducement, and pathological changes main body, at lobules of liver, is one of common DHD, store up too much with triglyceride in hepatocyte (TG) and diffusivity hepatic cell fattydegeneration for major pathologic features.
Generally speaking, fatty liver belongs to reversibility disease, and early diagnosis also treatment in time can recover normal, but as treated not in time, can further develop and become hepatitis, liver cirrhosis, hepatocarcinoma etc.The drug main being used for the treatment of fatty liver at present clinically will be divided into hypolipidemic, liver-protecting fat-dropping medicine and Chinese medicine three major types, hypolipidemic comprises fibrate, trihydroxy methyl glutaryl-CoA-reductase inhibitors etc., because fatty liver is often with Liver Lipid Metabolism obstacle, blood lipid-lowering medicine orders about blood fat and more concentrates on liver and carry out metabolism, and then infringement liver function.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of medicine for the treatment of fatty liver.
Technical scheme provided by the invention is a kind of medicine for the treatment of fatty liver, comprises the component of following weight portion: Herba Epimedii 4 ~ 10 parts, Folium Eriobotryae 3 ~ 6 parts, 1 ~ 3 part, Radix Glycyrrhizae, Radix Scutellariae 2 ~ 5 parts, Rhizoma Alismatis 2 ~ 7 parts, Radix Notoginseng 3 ~ 10 parts, 2 ~ 6 parts, Poria, Fructus Crataegi 1 ~ 5 part, Herba Artemisiae Scopariae 2 ~ 4 parts, Fructus Lycii 3 ~ 10 parts, Herba Abri 3 ~ 8 parts, Herb Gynostemmae Pentaphylli 3 ~ 6 parts, Radix Rhodiolae 1 ~ 5 part, Radix Salviae Miltiorrhizae 2 ~ 8 parts, green tea 3 ~ 8 parts.
Said medicine also comprises Fructus Lycopersici esculenti herb 3 ~ 10 parts, leaf of Herba Rosmarini Officinalis 1 ~ 5 part, 1 ~ 5 part, Folium olive.
The preparation method of said medicine is as follows: each raw material is added mixing and is placed in container, add the soak by water 3 times of inventory weight 10 ~ 20 times, each decoction 1 ~ 3h, merge decoction liquor, filter, it is the extractum of 1.20 ~ 1.30 that filtrate is concentrated into relative density at 60 DEG C, adds adjuvant, makes corresponding dosage form.
Medicine of the present invention has effect of depressed liver-energy dispersing and QI regulating, kidney and spleen invigorating, blood stasis dispersing and phlegm expelling dampness removing, blood circulation promoting and blood stasis dispelling, treatment fatty liver determined curative effect, rapid-action, effective, safe without toxic side effect.
Detailed description of the invention
The present invention is further elaborated for following specific embodiment, but not as a limitation of the invention.
Embodiment 1
Formula: Herba Epimedii 4kg, Folium Eriobotryae 3kg, Radix Glycyrrhizae 1kg, Radix Scutellariae 2kg, Rhizoma Alismatis 2kg, Radix Notoginseng 3kg, Poria 2kg, Fructus Crataegi 1kg, Herba Artemisiae Scopariae 2kg, Fructus Lycii 3kg, Herba Abri 3kg, Herb Gynostemmae Pentaphylli 3kg, Radix Rhodiolae 1kg, Radix Salviae Miltiorrhizae 2kg, green tea 3kg.
Preparation method: above-mentioned each raw material is placed in container, adds the soak by water 3 times of inventory weight 10 times, decocts 1h at every turn, merges decoction liquor, and filter, it is the extractum of 1.20 that filtrate is concentrated into relative density at 60 DEG C, adds adjuvant, makes tablet, every sheet 0.2g.
Embodiment 2
Formula: Herba Epimedii 10kg, Folium Eriobotryae 6kg, Radix Glycyrrhizae 3kg, Radix Scutellariae 5kg, Rhizoma Alismatis 7kg, Radix Notoginseng 10kg, Poria 6kg, Fructus Crataegi 5kg, Herba Artemisiae Scopariae 4kg, Fructus Lycii 10kg, Herba Abri 8kg, Herb Gynostemmae Pentaphylli 6kg, Radix Rhodiolae 5kg, Radix Salviae Miltiorrhizae 8kg, green tea 8kg.
Preparation method: above-mentioned each raw material is placed in container, adds the soak by water 3 times of inventory weight 20 times, decocts 3h at every turn, merges decoction liquor, and filter, it is the extractum of 1.30 that filtrate is concentrated into relative density at 60 DEG C, adds adjuvant, makes tablet, every sheet 0.2g.
Embodiment 3
Formula: Herba Epimedii 8kg, Folium Eriobotryae 5kg, Radix Glycyrrhizae 2kg, Radix Scutellariae 3kg, Rhizoma Alismatis 4kg, Radix Notoginseng 6kg, Poria 4kg, Fructus Crataegi 3kg, Herba Artemisiae Scopariae 3kg, Fructus Lycii 5kg, Herba Abri 5kg, Herb Gynostemmae Pentaphylli 4kg, Radix Rhodiolae 3kg, Radix Salviae Miltiorrhizae 6kg, green tea 5kg, Fructus Lycopersici esculenti herb 10kg, leaf of Herba Rosmarini Officinalis 5kg, Folium olive 5kg.
Preparation method: above-mentioned each raw material is placed in container, adds the soak by water 3 times of inventory weight 15 times, decocts 2h at every turn, merges decoction liquor, and filter, it is the extractum of 1.25 that filtrate is concentrated into relative density at 60 DEG C, adds adjuvant, makes pill, every 0.2g.
Embodiment 4
Formula: Herba Epimedii 4kg, Folium Eriobotryae 6kg, Radix Glycyrrhizae 1kg, Radix Scutellariae 5kg, Rhizoma Alismatis 2kg, Radix Notoginseng 10kg, Poria 2kg, Fructus Crataegi 5kg, Herba Artemisiae Scopariae 2kg, Fructus Lycii 10kg, Herba Abri 3kg, Herb Gynostemmae Pentaphylli 6kg, Radix Rhodiolae 1kg, Radix Salviae Miltiorrhizae 8kg, green tea 3kg, Fructus Lycopersici esculenti herb 10kg, leaf of Herba Rosmarini Officinalis 1kg, Folium olive 5kg.
Preparation method: above-mentioned each raw material is placed in container, adds the soak by water 3 times of inventory weight 10 times, decocts 3h at every turn, merges decoction liquor, and filter, it is the extractum of 1.20 that filtrate is concentrated into relative density at 60 DEG C, adds adjuvant, makes pill, every 0.2g.
For verifying effect of the present invention, applicant spy carries out following experiment.
1, physical data
Choose clinical case 400 example, male 226 example, women 174 example, 22 ~ 62 years old age, alcohol fatty hepatopath 189 example, nonalcoholic fatty liver disease 211 example.Be divided into 4 groups at random, often organize 100 examples, be respectively experimental group 1 ~ 4.
2, diagnostic criteria
" new Chinese medicine guideline of clinical investigations " that the People's Republic of China's traditional Chinese medicine industry standard " disease of tcm Standardization of diagnosis and curative effect " issued with reference to State Administration of Traditional Chinese Medicine and Ministry of Public Health are issued, diagnostic criteria is as follows:
Primary symptom: 1) weak; 2) hypochondriac pain; 3) abdominal distention.
Secondary disease: 1) the lower mass in the abdomen of the side of body; 2) indigestion and loss of appetite; 3) obesity; 4) light red tongue has indentation, white and thin fur, in vain greasy or BOHUANG and greasy; 5) stringy and rolling pulse or moisten.
All possess primary symptom, and secondary disease 1 can be defined as primary disease.
Tcm symptom quantization modulation standard:
3, Therapeutic Method
Experimental group 1 ~ 4 takes the medicine of embodiment 1 ~ 4 respectively, every day 1 time, and each 3 slices/for oral administration, within one week, be a course for the treatment of, the course for the treatment of is 4 weeks.
4, the standard of curative effect evaluation
Integration × 100% before TCM syndrome therapeutic index=(before treatment the rear integration of integration-treatment)/treatment
Effective: after terminating the course for the treatment of, TCM syndrome therapeutic index >=70%;
Effective: after treatment terminates, TCM syndrome therapeutic index >=30%;
Invalid: after treatment terminates, TCM syndrome therapeutic index < 30%.
5, therapeutic outcome
Group Effective Effectively Invalid Total effective rate (%)
Experimental group 1 42 48 10 90
Experimental group 2 46 45 9 91
Experimental group 3 52 41 7 93
Experimental group 4 48 43 9 91

Claims (3)

1. treat a medicine for fatty liver, it is characterized in that: the component comprising following weight portion: Herba Epimedii 4 ~ 10 parts, Folium Eriobotryae 3 ~ 6 parts, 1 ~ 3 part, Radix Glycyrrhizae, Radix Scutellariae 2 ~ 5 parts, Rhizoma Alismatis 2 ~ 7 parts, Radix Notoginseng 3 ~ 10 parts, 2 ~ 6 parts, Poria, Fructus Crataegi 1 ~ 5 part, Herba Artemisiae Scopariae 2 ~ 4 parts, Fructus Lycii 3 ~ 10 parts, Herba Abri 3 ~ 8 parts, Herb Gynostemmae Pentaphylli 3 ~ 6 parts, Radix Rhodiolae 1 ~ 5 part, Radix Salviae Miltiorrhizae 2 ~ 8 parts, green tea 3 ~ 8 parts.
2. the medicine for the treatment of fatty liver according to claim 1, is characterized in that: also comprise Fructus Lycopersici esculenti herb 3 ~ 10 parts, leaf of Herba Rosmarini Officinalis 1 ~ 5 part, 1 ~ 5 part, Folium olive.
3. the medicine for the treatment of fatty liver according to claim 1, it is characterized in that: its preparation method is as follows: each raw material is added mixing and is placed in container, add the soak by water 3 times of inventory weight 10 ~ 20 times, each decoction 1 ~ 3h, merge decoction liquor, filter, it is the extractum of 1.20 ~ 1.30 that filtrate is concentrated into relative density at 60 DEG C, add adjuvant, make corresponding dosage form.
CN201510058596.5A 2015-02-04 2015-02-04 Medicament for treating fatty liver Pending CN104587098A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510058596.5A CN104587098A (en) 2015-02-04 2015-02-04 Medicament for treating fatty liver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510058596.5A CN104587098A (en) 2015-02-04 2015-02-04 Medicament for treating fatty liver

Publications (1)

Publication Number Publication Date
CN104587098A true CN104587098A (en) 2015-05-06

Family

ID=53113369

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510058596.5A Pending CN104587098A (en) 2015-02-04 2015-02-04 Medicament for treating fatty liver

Country Status (1)

Country Link
CN (1) CN104587098A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102727686A (en) * 2012-07-20 2012-10-17 杨献华 Traditional Chinese medicine composition for treating fatty liver
CN102988629A (en) * 2011-09-08 2013-03-27 彭军 Medicine used for treating fatty liver

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102988629A (en) * 2011-09-08 2013-03-27 彭军 Medicine used for treating fatty liver
CN102727686A (en) * 2012-07-20 2012-10-17 杨献华 Traditional Chinese medicine composition for treating fatty liver

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
尹常健,等。: ""脂肪肝常用治法述要"", 《山东中医杂志》 *
王永怡,等。: "《脂肪肝防治与饮食调养必读》", 31 May 2009 *

Similar Documents

Publication Publication Date Title
CN102755594A (en) Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof
CN104644915A (en) Pharmaceutical composition for treating alcoholic liver diseases as well as preparation method and application of pharmaceutical composition
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN103330865B (en) Medicine for curing non-alcoholic steatohepatitis and preparation method thereof
CN103099944A (en) Drug for treating stubborn insomnia
CN102641430B (en) Traditional Chinese medicine decoction for treating diabetic nephropathy (DN)
CN102727787B (en) Drug with characteristics of rapid transaminase lowering and live protection
CN104043050A (en) Traditional Chinese medicine composition for treating cholecystitis
CN109954034A (en) A kind of preparation method for treating chill, wind-heat, the drug of influenza and its oral solution
CN103845429A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102579971A (en) Chinese medicine preparation for curing hyperplasia of mammary glands
CN101926903A (en) Chinese medicine preparation for curing facial paralysis
CN103100035B (en) Traditional Chinese medicine (TCM) decoction for treating globus hysteriocus
CN104721256A (en) Anwei Yang extract as well as preparation method and medical application thereof
CN105267818B (en) A kind of Chinese medicine composition and preparation method thereof for treating epigastric pain
CN103860882A (en) Medicinal preparation for treating chronic cervicitis
CN104587098A (en) Medicament for treating fatty liver
CN103007204B (en) Chinese medicinal composition for treating hepatofibrosis
CN102106992B (en) Chinese medicinal granules for treating non-alcoholic steatohepatitis
CN104800675A (en) Medicament for treating active ulcerative colitis
CN104288579A (en) Traditional Chinese medicine for treating chronic nephritis and preparation method thereof
CN104127602A (en) Traditional Chinese medicine for treating fatty liver
CN102335243B (en) Chinese medicinal composition for treating icteric hepatitis
CN103212033B (en) Drug composition for treating viral hepatitis
CN102166303B (en) Chinese medicinal composition for treating chronic atrophic gastritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150506

RJ01 Rejection of invention patent application after publication